Hutch News

Hutch News

Stories tagged 'hiv'

25 powerful years of HIV research

Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission

Feb. 26, 2018 | By Sabrina Richards / Fred Hutch News Service

For 25 years, Fred Hutch virologist Dr. Julie Overbaugh has helped lead the Mombasa Cohort, a unique group of women at high risk for HIV transmission.

View story >


Meet Global Oncology's deputy program head

Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health

Feb. 22, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Thomas Uldrick brings expertise in HIV-related cancers and experience in — and a passion for — developing clinical trials to his new position at Fred Hutch Global Oncology.

View story >


Microbiome research refines HIV risk for women

For the first time, seven species of vaginal bacteria linked to higher HIV susceptibility

Jan. 25, 2018 | By Sabin Russell / Fred Hutch News Service

Drawing from data collected for years by AIDS researchers in six African nations, scientists have pinpointed seven bacterial species whose presence in high concentrations may significantly increase the risk of HIV infection in women.

View story >


Meet Peru's HIV superhero

By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic

Jan. 22, 2018 | By Mary Engel / Fred Hutch News Service

A leader in Peru's battle against HIV/AIDS, Dr. Jorge Sanchez's superpower is research. He is working with the Fred Hutch-based HIV Vaccine Trials Network on a potentially landmark prevention study.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


New 'mosaic' HIV vaccine study launched for World AIDS Day

As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic

Dec. 1, 2017 | By Mary Engel / Fred Hutch News Service

The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.